SpaceX IPO: What It Means for European SpaceTech

Jan de Vries · 2026-06-15

SpaceX's record $75 billion IPO has created a new reference point for European SpaceTech founders and investors. The big question now is whether this listing will deepen investor appetite for the whole sector or just concentrate attention around one US leader. According to Reuters, the company priced its IPO at $135 per share. That values the satellite, rockets, and AI company at roughly $1.77 trillion. For European SpaceTech, this isn't just about one company going public. It's a test of how far space has moved into mainstream capital markets. ### Space Gets Its Public-Market Moment Mark Boggett, CEO of the British space investment firm Seraphim Space, sees this as a turning point. He says: "A SpaceX IPO is a landmark moment for the space economy. More than simply attracting additional venture capital, it would further establish space as a mainstream investment category and provide public market investors with a highly visible benchmark for the sector's potential." Boggett also thinks the impact goes beyond venture capital. He believes it could bring in capital from institutional investors, wealth managers, retail investors, and public market participants. That broader signal matters for Europe. Companies here are building across launch, satellite infrastructure, Earth observation, communications, DefenseTech, climate intelligence, and space-enabled applications. ### Europe Reads the Signal While SpaceX is closely tied to rockets and Starlink, several European voices argue the biggest implications are beyond launch. José Manuel Rodríguez, CFO of the Spanish SpaceTech company PLD Space, sees the IPO as part of the sector's maturation, not just a SpaceX story. He says: "This kind of movement is a natural evolution of the sector and, overall, a positive development. It helps bring visibility to an industry that, until recently, operated largely outside the public conversation." For PLD Space, that visibility also strengthens the case for European autonomy. SpaceX's listing might validate the launch market, but it also shows why Europe needs its own competitive space transportation capabilities. ### Beyond Rockets and Starlink Bruno Santos, co-founder and Head of R&D at the Luxembourg Space BioTech startup Exobiosphere, echoes that theme of validation without automatic advantage. He sees the IPO as a signal that space is becoming understandable to generalist investors. But he warns that capital may still flow first to the most visible parts of the market. Santos puts it this way: "It's the signal that tells generalist investors space is a real asset class and not a moonshot. That changes the room. Founders doing serious work in orbit start getting taken seriously, and money that wouldn't have looked at the sector now does." The risk, he says, is that investors focus on launch and constellations while missing the application layers where space infrastructure could unlock value in other sectors. For Exobiosphere, that means drug discovery, disease modeling, advanced biomanufacturing, and other work that behaves differently in microgravity. "So the IPO makes 'space' investable much faster than it makes 'space-enabled BioTech' investable. That gap is the opportunity, and also where we get hurt," Santos adds. "Validation without capital just tells your better-funded competitors where to aim." ### What This Means for Founders If you're a European SpaceTech founder, here's what to take away: - **More visibility**: The IPO puts space on the map for mainstream investors. - **But capital might be uneven**: Launch and constellations could get the most attention first. - **Application layers need focus**: Areas like biotech or climate intelligence may take longer to attract funding. - **European autonomy matters**: The IPO highlights the need for homegrown capabilities. Santos sums it up: capital isn't the only thing. Timing and focus matter just as much. The IPO opens doors, but you still have to walk through them with a clear plan.